CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Esa Medika Mandiri Tbk PT is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Esa Medika Mandiri Tbk PT
Phone: +62 2139702800p:+62 2139702800 15332  Indonesia Ticker: EMMIEMMI

Business Summary
PT Esa Medika Mandiri Tbk is a health care provider. The Company's medical products include Anesthesia Machine, Electrocardiograph, Electrosurgery Unit & Ultrasonic Scalpel, Examination & Operating Light, High Flow Oxygen Therapy, Minimal Invasive Surgery System and Instrument Set, Modular Operating Theater, Obstetric Unit, Operating Table, Patient Monitoring, Surgical Instrument - Medicon, Surgical Instrument - SURGITEC, Infusion & Syringe Pump, and Ventilator. Its Anesthesia Machine includes Caelus Lite, Prima 450, Prima 460, and Prima 465. Its Electrocardiograph products include EKG 300 and EKG 1200. Its Electrosurgery Unit & Ultrasonic Scalpel products include ARC 350, ARC 400, and Lotus LG4. Its Examination & Operating Light products include Sim.LED 700/500, Sim.LED 7000/5000-Operating Lamp, and Sim.LED 350 - Examination Lamp. Its High Flow Oxygen Therapy product is Telesair. Infusion & Syringe Pump products include INP 1000 and SYP 100.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202512/31/2025-----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Commissioner Surya G.Widjaja 72 1/1/2026 1/1/2026
President Director Florian C.Widjaja 39 1/1/2026 1/1/2026
Director EddyLie 64 1/1/2000 1/1/2000
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 92 (As of 12/31/2025)
Outstanding Shares: 1,742,857,000 (As of 12/31/2025)
Stock Exchange: JAK


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, August 1, 2026